0338-0086-01 |
0338-0086 |
HUMAN PRESCRIPTION DRUG |
Doxorubicin Hydrochloride Liposome |
Doxorubicin Hydrochloride Liposome |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20190815 |
N/A |
NDA AUTHORIZED GENERIC |
NDA050718 |
Baxter Healthcare Corporation |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-USE in 1 CARTON (0338-0086-01) / 25 mL in 1 VIAL, SINGLE-USE |
0338-0063-01 |
0338-0063 |
HUMAN PRESCRIPTION DRUG |
DOXIL |
doxorubicin hydrochloride |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20190813 |
N/A |
NDA |
NDA050718 |
Baxter Healthcare Corporation |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-USE in 1 CARTON (0338-0063-01) / 10 mL in 1 VIAL, SINGLE-USE |
0338-0080-01 |
0338-0080 |
HUMAN PRESCRIPTION DRUG |
Doxorubicin Hydrochloride Liposome |
Doxorubicin Hydrochloride Liposome |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20190815 |
N/A |
NDA AUTHORIZED GENERIC |
NDA050718 |
Baxter Healthcare Corporation |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-USE in 1 CARTON (0338-0080-01) / 10 mL in 1 VIAL, SINGLE-USE |
0338-9667-01 |
0338-9667 |
HUMAN PRESCRIPTION DRUG |
DOXIL |
doxorubicin hydrochloride |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20240826 |
N/A |
NDA |
NDA050718 |
Baxter Healthcare Corporation |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (0338-9667-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
0338-0067-01 |
0338-0067 |
HUMAN PRESCRIPTION DRUG |
DOXIL |
doxorubicin hydrochloride |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVITREAL |
20190813 |
N/A |
NDA |
NDA050718 |
Baxter Healthcare Corporation |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-USE in 1 CARTON (0338-0067-01) / 25 mL in 1 VIAL, SINGLE-USE |
0338-9665-01 |
0338-9665 |
HUMAN PRESCRIPTION DRUG |
DOXIL |
doxorubicin hydrochloride |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20240826 |
N/A |
NDA |
NDA050718 |
Baxter Healthcare Corporation |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (0338-9665-01) / 25 mL in 1 VIAL, SINGLE-DOSE |